[The triacetyloleandomycin in the medium spectrum group of antibiotics. Clinico-experimental contribution in the pediatric field].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D002627:Chemistry, Physical; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D007239:Infections / Q000188:drug therapy; D008099:Liver / Q000201:enzymology; D008297:Male; D008826:Microbial Sensitivity Tests; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy; D010372:Pediatrics; D011182:Postoperative Care; D011300:Preoperative Care; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D000637:Transaminases / Q000097:blood; D014217:Troleandomycin / Q000009:adverse effects / Q000032:analysis / Q000378:metabolism / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014217:Troleandomycin; D000637:Transaminases
La triacetiloleandomicina nel novero degli antibiotici a medio spettro. Contributo clinico-sperimentale in campo pediatrico.